Skip Navigation
Skip to contents

대한신장학회


간행물 검색

현재 페이지 경로
  • HOME
  • 간행물
  • 간행물 검색
논문분류 춘계학술대회 초록집
제목 An observational study for Non-invasive detection of tacrolimus toxicity and graft injury using urine cellular RNA expression in kidney transplantation
저자 Jungwoo SEO1, Haena MOON1, Yu ho LEE1, Yang-gyun KIM1, Kyung-hwan JEONG1, Chan-duck KIM2, Byung ha JEONG3, Jae berm PARK4, Ju-young MOON1, *Sang-ho LEE1
출판정보 2017; 2017(1):
키워드 kidney transplantation, CNI toxicity, urinary mRNA
초록 Objectives : Although immunosuppressive drugs have improved to reduce renal allograft rejection, renal allograft failure has not markedly diminished. Biochemical examination and invasive biopsy have low sensitivity for diagnosis of tacrolimus toxicity and kidney injury in kidney transplantation. Therefore, the development of non-invasive diagnosis for tacrolimus toxicity and acute and chronic kidney injury using expression level of urinary mRNA is required for long-term graft survival in the kidney transplant patients. Methods : 110 urine specimens (35 stable, 30 acute rejection (AR), 15 acute calcineurin inhibitor nephrotoxicity (CNI), 10 chronic CNI and 20 acute tubular necrosis (ATN)) were collected after transplantation. RNA extracted from urine pellets was reverse-transcribed and 4 transcripts associated with calcinurin inhibitor toxicity in microarray results published by Maluf et al were investigated using real-time PCR. Results : Four transcripts (LTF, NNMT, WFDC2, and HIF1A) were selected in published microarray data for diagnosing tacrolimus toxicity by real-time PCR analysis. The expression levels of LTF, NNMT, and HIF1A were significantly decreased in CNI group while 18S were increased. There was no difference of the expression of WFDC2 mRNA between groups. These transcripts discriminated patients with tacrolimus toxicity from patients with ATN and AR. A combination of mRNAs for 18S, LTF, NNMT, and HIF1A that distinguishes CNI from ATN and AR yielded the area under the curve of 0.94 and 0.87, respectively. Conclusions : We investigated genetic biomarkers to develop a noninvasive diagnostic assay in urine of kidney transplant patients. These urinary mRNAs may be useful to non-invasively monitor allograft kidney in clinical decisions.
원문(PDF) PDF 원문보기
위로가기